| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.003 | 1 |